Encodes An Enzyme Patents (Class 536/23.2)
  • Publication number: 20120110703
    Abstract: This invention provides DNAs of a prenyltransferase derived from a hop (Humulus) plant. The invention also provides protein having the prenyltransferase activity of a hop plant and a method for producing and detecting a novel organism using a gene encoding such protein.
    Type: Application
    Filed: June 18, 2010
    Publication date: May 3, 2012
    Applicant: KIRIN HOLDINGS KABUSHIKI KAISHA
    Inventors: Kazufumi Yazaki, Naoyuki Umemoto, Masaki Momose
  • Publication number: 20120107899
    Abstract: The present invention relates to use of Caminibacter carbonic anhydrase in CO2 extraction, e.g., from flue gas, natural gas, biogas or ambient air. The Caminibacter carbonic anhydrases are especially well suited for these purpose due to their extreme thermostability.
    Type: Application
    Filed: June 25, 2010
    Publication date: May 3, 2012
    Applicants: NOVOZYMES NORTH AMERICA, INC., NOVOZYMES A/S
    Inventors: Martin Borchert, Paria Saunders
  • Publication number: 20120107903
    Abstract: A mutant glucose dehydrogenase having an amino acid sequence at least 80% identical to SEQ ID NO:3 and having glucose dehydrogenase activity, wherein amino acid residues corresponding to positions 326, 365 and 472 of said amino acid sequence are replaced with glutamine, tyrosine and tyrosine, respectively, and wherein said mutant glucose dehydrogenase shows an improved substrate specificity to glucose and a reduced reactivity to disaccharides.
    Type: Application
    Filed: October 26, 2011
    Publication date: May 3, 2012
    Applicants: BIOENGINEERING LABORATORIES, LLC, ARKRAY, Inc.
    Inventors: Koji Sode, Katsuhiro Kojima
  • Publication number: 20120107906
    Abstract: The present invention provides a novel nucleic acid sequence, designated LIP1, encoding a lipolytic enzyme and the corresponding encoded amino acid sequences. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding at least one novel lipolytic enzyme, recombinant lipolytic enzyme proteins and methods for producing the same.
    Type: Application
    Filed: January 12, 2012
    Publication date: May 3, 2012
    Inventors: Brian E. Jones, William D. Grant, Shaun Heaphy, Susan Grant, Helen Rees
  • Publication number: 20120107889
    Abstract: The present invention provides novel endophytic yeast strains capable of metabolizing both pentose and hexose sugars. Methods of producing ethanol and xylitol using the novel endophytic yeast are provided herein. Also provided are methods of fixing nitrogen and fertilizing a crop using the novel endophytic yeast strains provided herein.
    Type: Application
    Filed: March 12, 2010
    Publication date: May 3, 2012
    Inventors: Sharon L. Doty, James Staley, Michael Su, Azra Vajzovic, Renata Bura, Regina Redman, Zareen Khan
  • Publication number: 20120107342
    Abstract: Described is an ex vivo animal or challenge model used as a method to identify protective (e.g., recombinant) proteins and rapidly measure protective immunity in intestinal segments directed against parasites and vaccines directed against parasitic infections. Further described are vaccines directed against infection with parasites, such as Fasciola hepatica, which vaccines contain protective (recombinant) proteins identified and shown to be protective in studies using the ex vivo model. Further described are protective (e.g., recombinant) proteins obtained from newly excysted juveniles (NEJ) of F. hepatica. The protective (recombinant) protein corresponding to an NEJ protein has an apparent molecular weight of 32 kD and an N-terminal amino acid molecule comprising the sequence XXDVSWPFWDRMYNY (SEQ ID NO:1).
    Type: Application
    Filed: November 14, 2011
    Publication date: May 3, 2012
    Inventors: Florine Johanna van Milligen, Johannes Bernardus Wilhelmus Joseph Cornelissen, Bernard Adri Bokhout
  • Publication number: 20120108493
    Abstract: The present invention relates to polypeptide fragments comprising an amino-terminal fragment of the PA subunit of a viral RNA-dependent RNA polymerase or variants thereof possessing endonuclease activity, wherein said PA subunit is from a virus belonging to the Orthomyxoviridae family. This invention also relates to (i) crystals of the polypeptide fragments which are suitable for structure determination of said polypeptide fragments using X-ray crystallography and (ii) computational methods using the structural coordinates of said polypeptide to screen for and design compounds that modulate, preferably inhibit the endonucleolytically active site within the polypeptide fragment. In addition, this invention relates to methods identifying compounds that bind to the PA polypeptide fragments possessing endonuclease activity and preferably inhibit said endonucleolytic activity, preferably in a high throughput setting.
    Type: Application
    Filed: December 18, 2009
    Publication date: May 3, 2012
    Inventors: Denis Bouvier, Thibaut Crepin, Rob Rulgrok, Alexander Dias, Stephen Cusack
  • Publication number: 20120107904
    Abstract: Compositions and methods are provided that are useful for predicting and controlling the stability of expressed polypeptides. The compositions and methods may be used to predict and as desired, increase or decrease the stability of proteins recombinantly expressed in mycobacteria, for example DesA3 expressed in Mycobacterium smegmatis. At the C terminus and the penultimate position, substitution to residues with charged side chains, large non-polar side chains, or no side chains can be used to reduce or inhibit the protein degradation. At the antepenultimate position from the C terminus, residues with no side chain or acidic side chains can increase the stability, i.e. reduce or inhibit the protein degradation. The combinational substitution of only the last three residues of polypeptides can make the polypeptides more stable during heterologous expression in mycobacterial hosts.
    Type: Application
    Filed: April 28, 2009
    Publication date: May 3, 2012
    Inventors: Brian G. Fox, Yong Chang, Gary A. Wesenberg, Craig A. Bingman
  • Publication number: 20120110688
    Abstract: This invention relates to soybean event pDAB4472-1606 (Event 1606). This invention includes a novel aad-12 transformation event in soybean plants comprising a polynucleotide sequence, as described herein, inserted into a specific site within the genome of a soybean cell. This invention also relates in part to plant breeding and herbicide tolerant plants. In some embodiments, said event/polynucleotide sequence can be “stacked” with other traits, including, for example, other herbicide tolerance gene(s) and/or insect-inhibitory proteins.
    Type: Application
    Filed: September 7, 2011
    Publication date: May 3, 2012
    Applicant: Dow AgroSciences LLC
    Inventors: Yunxing C. Cui, Thomas Hoffman, Ning Zhou, Gregory J. Gilles, Terry R. Wright, Dawn M. Parkhurst, Julissa Colon, Yonghe Bai
  • Publication number: 20120107905
    Abstract: The present invention relates to fungal serine protease variants, which comprise an amino acid substitution of valine at position 208 of the parent Fusarium equiseti Fe_RF6318 serine protease, wherein the position of the substitution corresponds to the amino acid sequence of the mature Fe_RF6318 enzyme defined in SEQ ID NO:2. The variants have improved thermal stability and/or detergent stability compared to the parent Fe_RF6318 enzyme. Preferably the substitution is V208I and more preferably the variants comprise additional amino acid changes which further increase the stability. Also disclosed are nucleic acid sequences encoding said protease variants as well as recombinant vectors and host cells for the production of the variants.
    Type: Application
    Filed: October 28, 2011
    Publication date: May 3, 2012
    Applicant: AB ENZYMES OY
    Inventors: Kari Juntunen, Leena Valtakari, Nina Hakulinen, Marja Paloheimo
  • Publication number: 20120110694
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a Myb-related transcription factor. The invention also relates to the construction of a chimeric gene encoding all or a portion of the Myb-related transcription factor, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the Myb-related transcription factor in a transformed host cell.
    Type: Application
    Filed: January 2, 2012
    Publication date: May 3, 2012
    Inventors: Rebecca E. Cahoon, Viwen Fang, Joan T. Odell, Zude Weng
  • Publication number: 20120107907
    Abstract: The present invention provides methods and compositions comprising at least one neutral metalloprotease enzyme that has improved storage stability. In some embodiments, the neutral metalloprotease finds use in cleaning and other applications. In some particularly preferred embodiments, the present invention provides methods and compositions comprising neutral metalloprotease(s) obtained from Bacillus sp. In some more particularly preferred embodiments, the neutral metalloprotease is obtained from B. amyloliquefaciens. In still further preferred embodiments, the neutral metalloprotease is a variant of the B. amyloliquefaciens neutral metalloprotease. In yet additional embodiments, the neutral metalloprotease is a homolog of the B. amyloliquefaciens neutral metalloprotease. The present invention finds particular use in applications including, but not limited to cleaning, bleaching and disinfecting.
    Type: Application
    Filed: January 6, 2012
    Publication date: May 3, 2012
    Inventors: Andrew Shaw, Louise Wallace, David A. Estell, Ronald W. J. Hommes, Sang-Kyu Lee, Hiroshi Oh, Eugene S. Sadlowski
  • Patent number: 8168770
    Abstract: A method of preventing or inhibiting infection by a parasite or virus in vivo comprising administering to a human in need thereof a parasite or virus mitogen in a sub-mitogenic amount sufficient to induce a protective immune response against the parasite or virus in the human.
    Type: Grant
    Filed: March 17, 2006
    Date of Patent: May 1, 2012
    Assignees: Centre National de la Recherche Scientifique, Instituto Gulbekian De Cienca
    Inventors: Paolo Minoprio, Mario Arala-Chaves, Eduarda Maria Santos Dores Arala Chaves, legal representative, Rui Mario Dores Arala Chaves, legal representative, Antonio Coutinho, Bernardo Reina San Martin, Catherine Rougeot, Wim Degrave, Alain Cosson
  • Patent number: 8168392
    Abstract: By finding a novel tetrahydrofolate synthetase gene and a protein encoded by said gene, a method for identifying a compound which inhibits cell growth accelerating activity of said protein is provided, and a judging method, a preventing method and a treating method of colon cancer are provided. A DNA comprising a nucleotide sequence of from the 94th to 2934th positions of the nucleotide sequence of SEQ ID NO:1 of the SEQUENCE LISTING; a polynucleotide which specifically hybridizes with said DNA; a protein encoded by said DNA; a recombinant vector comprising said DNA; a transformant comprising said recombinant vector; an antibody for said protein; a method for producing said protein; a method for identifying a compound which inhibits cell growth accelerating activity possessed by said protein; a method for judging colon cancer, characterizing in that expressed amount of said DNA is measured; a kit for judging colon cancer; a preventive agent and/or therapeutic agent for colon cancer.
    Type: Grant
    Filed: April 8, 2009
    Date of Patent: May 1, 2012
    Assignee: Daiichi Sankyo Co., Ltd.
    Inventor: Takeyuki Sugiura
  • Patent number: 8168176
    Abstract: Methods of treating endotoxin-mediated disorders are provided.
    Type: Grant
    Filed: November 12, 2007
    Date of Patent: May 1, 2012
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: Kurt Bachmaier, Asrar B. Malik
  • Patent number: 8168862
    Abstract: This invention relates to isolated nucleic acid fragments encoding fructosyltransferases. More specifically, this invention relates to polynucleotides encoding 1-FFTs, 6-SFTs, or 1-SSTs. The invention also relates to the construction of a recombinant DNA constructs encoding all or a portion of the fructosyltransferases, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels of the fructosyltransferases in a transformed host cell.
    Type: Grant
    Filed: January 21, 2011
    Date of Patent: May 1, 2012
    Assignee: E.I. du Pont de Nemours and Company
    Inventors: Johan M. Stoop, Stephen M. Allen, Perry G. Caimi, Karlene H. Butler
  • Patent number: 8168863
    Abstract: Compositions and methods for increasing the expression and/or accumulation of cellobiohydrolase enzyme in the vacuoles of plant cells are provided. The method involves targeting the enzyme to the vacuoles through the use of a barley polyamine oxidase (BPAO) vacuole sorting signal peptide. Plants transformed with an expression construct encoding the vacuole sorting signal peptide operably linked to the cellobiohydrolase enzyme direct expression of the polypeptide to the vacuoles of the plant cells. Transgenic plants, seeds, and plant tissues, and plant parts are provided. Downstream uses of transgenic plants or plant material expressing the constructs of the invention include agronomical and industrial uses, for example, human food, animal feed, biofuel, industrial alcohol, fermentation feedstocks, and the like.
    Type: Grant
    Filed: January 26, 2009
    Date of Patent: May 1, 2012
    Assignee: Syngenta Participations AG
    Inventor: Stacy Miles
  • Patent number: 8168383
    Abstract: Novel gene deletions and translocations involving chromosome 2 resulting in fusion proteins combining part of Anaplastic Lymphoma Kinase (ALK) kinase with part of a secondary protein have now been identified in human solid tumors, e.g. non-small cell lung carcinoma (NSCLC). Secondary proteins include Echinoderm Microtubule-Associated Protein-Like 4 (EML-4) and TRK-Fusion Gene (TFG). The EML4-ALK fusion protein, which retains ALK tyrosine kinase activity, was confirmed to drive the proliferation and survival of NSCLC characterized by this mutation. The invention therefore provides, in part, isolated polynucleotides and vectors encoding the disclosed mutant polypeptides, probes for detecting it, isolated mutant polypeptides, and reagents for detecting the fusion and truncated polypeptides.
    Type: Grant
    Filed: October 19, 2009
    Date of Patent: May 1, 2012
    Assignee: Cell Signaling Technology, Inc.
    Inventors: Klarisa Rikova, Herbert Haack, Laura Sullivan, Ailan Guo, Anthony Possemato, Joan MacNeill, Ting-Lei Gu, Jian Yu
  • Patent number: 8168422
    Abstract: The present invention relates to a microorganism producing inosine, which is one of purine nucleoside, an important material for 5?-inosinic acid synthesis, and method for producing inosine using the same. More particularly, the present invention relates to a recombinant microorganism of Corynebacterium genus producing inosine at high concentration by inactivating the gene encoding nucleoside hydrolase II and by enhancing the expression of the gene encoding 5?-nucleotidase, which still retains the characteristics of Corynebacterium ammoniagenes CJIP2401 (KCCM-10610).
    Type: Grant
    Filed: January 15, 2008
    Date of Patent: May 1, 2012
    Assignee: CJ Cheiljedang Corporation
    Inventors: Young-hoon Park, Kwang-myung Cho, Hee-jong Lee, Jin-nam Lee
  • Patent number: 8168414
    Abstract: The present invention concerns a new ?-galactosidase with transgalactosylating activity isolated from Bifidobacterium bifidum. The ?-galactosidase is capable of converting lactose to a mixture of galactooligosaccharides which are ?-linked and unexpectedly produces the ?-linked disaccharide galactobiose. The mixture may be incorporated into numerous food products or animal feeds for improving gut health by promoting the growth of bifidobacteria in the gut, and repressing the growth of the pathogenic microflora.
    Type: Grant
    Filed: March 27, 2007
    Date of Patent: May 1, 2012
    Assignee: Clasado Inc.
    Inventors: Georgios Tzortzis, Athanasios K Goulas, Theodoros Goulas
  • Patent number: 8168417
    Abstract: The present invention relates to an isolated polynucleotide of the complete chromosome of Bacillus licheniformis. The present invention also relates to isolated genes of the chromosome of Bacillus licheniformis which encode biologically active substances and to nucleic acid constructs, vectors, and host cells comprising the genes as well as methods for producing biologically active substances encoded by the genes and to methods of using the isolated genes of the complete chromosome of Bacillus licheniformis.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: May 1, 2012
    Assignees: Novozymes A/S, Novozymes, Inc.
    Inventors: Randy Berka, Michael Rey, Preethi Ramaiya, Jens Tønne Andersen, Michael Dolberg Rasmussen, Peter Bjarke Olsen
  • Patent number: 8168865
    Abstract: The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: December 19, 2011
    Date of Patent: May 1, 2012
    Assignees: Novozymes, Inc., Novozymes A/S
    Inventors: Paul Harris, Elena Vlasenko, Marcus Sakari Kauppinnen, Elizabeth Zaretsky
  • Publication number: 20120100250
    Abstract: The present invention relates to carbohydrate oxidases. The present invention also relates to polynucleotides encoding the variant carbohydrate oxidases and to nucleic acid constructs, vectors, and host cells comprising the polynucleotides, and methods of using the variant enzymes, such as, in preparing dough and dough product compositions.
    Type: Application
    Filed: July 9, 2010
    Publication date: April 26, 2012
    Applicant: NOVOZYMES A/S
    Inventors: Lars Henrik Oestergaard, Leonardo De Maria
  • Publication number: 20120100618
    Abstract: Disclosed is the HIS7 gene encoding the His7p enzyme in the histidine biosynthesis pathway of Pichia pastoris. The locus in the Pichia pastoris genome encoding the His7p is useful sites for stable integration of heterologous nucleic acid molecules into the Pichia pastoris genome. The gene or gene fragment encoding the His7p may be useful as a selection marker for constructing recombinant Pichia pastoris.
    Type: Application
    Filed: October 13, 2011
    Publication date: April 26, 2012
    Inventor: Juergen Nett
  • Publication number: 20120100619
    Abstract: Disclosed are the MET1, MET3, MET4, MET6, MET7, MET8, MET10, MET14, MET16, MET17, MET19, MET22, MET2, and MET28 genes encoding various enzymes in the methionine biosynthesis pathway of Pichia pastoris. The loci in the Pichia pastoris genome encoding these enzymes are useful sites for stable integration of heterologous nucleic acid molecules into the Pichia pastoris genome. The genes or gene fragments encoding the particular enzymes may be used as selection markers for constructing recombinant Pichia pastoris.
    Type: Application
    Filed: October 13, 2011
    Publication date: April 26, 2012
    Inventor: Juergen Nett
  • Publication number: 20120100530
    Abstract: The invention relates to constructs comprising a nucleic acid binding protein and a surface. At least one native accessible cysteine residue is removed from the binding protein. The binding protein is attached to the surface via one or more accessible cysteine residues. The removal of other accessible cysteine residues from the protein allows control attachment to the surface. The constructs can be used to generate transmembrane pores having a nucleic acid binding protein attached thereto. Such pores are particularly useful for sequencing nucleic acids. The enzyme handles the nucleic acid in such a way that the pore can detect each of its component nucleotides by stochastic sensing.
    Type: Application
    Filed: January 29, 2010
    Publication date: April 26, 2012
    Applicant: OXFORD NANOPORE TECHNOLOGIES LIMITED
    Inventors: Ruth Moysey, Michael Knaggs, Lakmal Jayasinghe, James White, Brian Mckeown, John Milton
  • Publication number: 20120100622
    Abstract: Disclosed are the URA1, URA2, URA4, and URA6 genes encoding various enzymes in the uracil biosynthesis pathway of Pichia pastoris. The loci in the Pichia pastoris genome encoding these enzymes are useful sites for stable integration of heterologous nucleic acid molecules into the Pichia pastoris genome. The genes or gene fragments encoding the particular enzymes may be used as selection markers for constructing recombinant Pichia pastoris.
    Type: Application
    Filed: October 13, 2011
    Publication date: April 26, 2012
    Inventor: Juergen Nett
  • Publication number: 20120101019
    Abstract: The present invention relates to novel JP170 like subtilases from wild-type bacteria, hybrids thereof and to methods of construction and production of these proteases. Further, the present invention relates to use of the claimed subtilases in detergents, such as a laundry or an automatic dishwashing detergent.
    Type: Application
    Filed: January 5, 2012
    Publication date: April 26, 2012
    Applicant: NOVOZYMES A/S
    Inventors: Preben Nielsen, Poul Erik Pedersen, Helle Outtrup
  • Publication number: 20120100582
    Abstract: The invention relates to an isolated polypeptide having esterase activity comprising an amino acid sequence shown in any one of SEQ ID NO's 2, 4, 6, 8, 10, 12 or 14 or a homologue thereof, comprising an amino acid substitution or deletion of one or more amino acids as shown in said SEQ ID NO's and resulting in a mutant polypeptide having an increased concentration of the fraction of the mutant polypeptide being present as an active and soluble protein in cleared lysate of the mutant polypeptide expressed in E. coli relative to the concentration of the fraction of the polypeptide without the mutation being present as an active and soluble protein in cleared lysate of the polypeptide without the one or more deletion or substitution expressed in E. coli under the same conditions. The invention also relates to nucleic acid encoding the polypeptides according to the invention, and the use of the polypeptides.
    Type: Application
    Filed: April 26, 2010
    Publication date: April 26, 2012
    Inventors: Martin Kietzmann, Harald Pichler, Helmut Schwab, Amin El-Heliebi, Christine Winkler, Andreas Braun
  • Publication number: 20120100596
    Abstract: The present invention relates to isolated polypeptides having organophosphorous hydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: May 6, 2010
    Publication date: April 26, 2012
    Applicant: NOVOZYMES A/S
    Inventors: Steffen Danielsen, Lars Kobberoee Skov, Ricardo Leite, Vincent Laize, M Leonor Cancela Da Fonseca
  • Publication number: 20120100617
    Abstract: Disclosed are the ADE3, ADE4, ADE5, 7, ADE6, ADE8, ADE12, and ADE13 genes encoding various enzymes in the adenine biosynthesis pathway of Pichia pastoris. The loci in the Pichia pastoris genome encoding these enzymes are useful sites for stable integration of heterologous nucleic acid molecules into the Pichia pastoris genome. The genes or gene fragments encoding the particular enzymes, which may be used as selection markers for constructing recombinant Pichia pastoris.
    Type: Application
    Filed: October 13, 2011
    Publication date: April 26, 2012
    Inventor: Juergen Nett
  • Publication number: 20120100249
    Abstract: The present invention relates to a protein which exhibits asparaginase activity and which has an amino acid sequence according to SEQ ID NO. 2-SEQ ID NO.10. The advantage of the protein of the present invention is that it exhibits asparaginase activity (EC 3.5.1.1) with a specific activity at acidic, neutral and alkaline pH which is many times higher than the specific activity of wild-type asparaginase.
    Type: Application
    Filed: April 22, 2011
    Publication date: April 26, 2012
    Applicant: DSM IP ASSETS B.V.
    Inventors: JAN METSKE VAN DER LAAN, IISE DE LANGE, MARK CRISTIAAN STOR
  • Publication number: 20120100584
    Abstract: An object of the present invention is to provide a DOI synthase having properties such as stability to heat and pH, which are superior to those of conventional enzymes, and a method for producing DOI using the above-mentioned enzyme. The present invention provides a 2-deoxy-scyllo-inosose synthase having the properties described in the following (1), (2), (4), (6) and (7), and also having the properties described in the following (3) and/or (5): (1) action: the enzyme has a function to convert glucose-6-phosphate to 2-deoxy-scyllo-inosose; (2) optimum pH range: pH 7.0 to 7.7; (3) stable pH range: pH 6.0 to 8.0; (4) optimum temperature range: 55° C. to 70° C.; (5) stable temperature range: 20° C. to 46° C.; (6) coenzyme used: NAD+; and (7) molecular weight: 39,000 to 42,000.
    Type: Application
    Filed: March 26, 2010
    Publication date: April 26, 2012
    Inventors: Kazunobu Konishi, Shinichi Imazu
  • Publication number: 20120100581
    Abstract: The invention provides novel polypeptides having phospholipase activity, including, e.g., phospholipase A, B, C and D activity, patatin activity, phosphatidic acid phosphatases (PAP)) and/or lipid acyl hydrolase (LAH) activity, nucleic acids encoding them and antibodies that bind to them. Industrial methods, e.g., oil degumming, and products comprising use of these phospholipases are also provided.
    Type: Application
    Filed: April 20, 2011
    Publication date: April 26, 2012
    Applicant: VERENIUM CORPORATION
    Inventors: SVETLANA GRAMATIKOVA, GEOFF HAZLEWOOD, DAVID LAM, NELSON R. BARTON, BLAKE G. STURGIS, DAN E. ROBERTSON, JINCAI LI, JOEL A. KREPS, RODERICK JAMES FIELDING, ROBERT C. BROWN, AMIT VASAVADA, XUQIU TAN, ADRIAN BADILLO, WILHELMUS P. VAN HOEK, GISELLE JANSSEN, CHARLES ISAAC, MARK J. BURK
  • Publication number: 20120100621
    Abstract: Disclosed are the ARG5, 6, ARG8, ARG9, ARG80, ARG81, and ARG82 genes encoding various enzymes in the arginine biosynthesis pathway of Pichia pastoris. The loci in the Pichia pastoris genome encoding these enzymes are useful sites for stable integration of heterologous nucleic acid molecules into the Pichia pastoris genome. The genes or gene fragments encoding the particular enzymes may be used as selection markers for constructing recombinant Pichia pastoris.
    Type: Application
    Filed: October 13, 2011
    Publication date: April 26, 2012
    Inventor: Juergen Nett
  • Publication number: 20120102596
    Abstract: Compositions related to the quantitative trait locus 6 (QTL6) in maize and methods for their use are provided. The compositions are novel molecular marker loci genetically linked with QTL6 and which are associated with increased oil content and/or increased oleic acid content and/or an increased oleic acid/linoleic acid ratio of a plant. These novel markers are characterized by the presence of at least one polymorphism relative to the corresponding marker locus from the QTL6 region of non-high-oil, non-high-oleic acid maize plants. In some embodiments, the novel marker loci comprise coding sequence for a maize DGAT1-2 polypeptide or biologically active variant thereof. The marker loci of the invention, and suitable fragments thereof, are useful in methods for manipulating oil and/or oleic acid content and/or oleic acid/linoleic acid ratio of a plant, for marker-assisted selection of a plant, and for marker-assisted breeding of the high oil and/or high oleic acid trait.
    Type: Application
    Filed: November 18, 2011
    Publication date: April 26, 2012
    Applicants: E.I. du Pont de Nemours and Company, Pioneer Hi-Bred International, Inc.
    Inventors: William B. Allen, Bo Shen, Mitchell C. Tarczynski, Mark E. Williams, Peizhong Zheng, Gan-Yuan Zhong
  • Publication number: 20120100620
    Abstract: Disclosed are the LYS1, LYS2, LYS4, LYS5, and LYS9 genes encoding various enzymes in the lysine biosynthesis pathway of Pichia pastoris. The loci in the Pichia pastoris genome encoding these enzymes are useful sites for stable integration of heterologous nucleic acid molecules into the Pichia pastoris genome. The genes or gene fragments encoding the particular enzymes may be used as selection markers for constructing recombinant Pichia pastoris.
    Type: Application
    Filed: October 13, 2011
    Publication date: April 26, 2012
    Inventor: Juergen Nett
  • Patent number: 8163980
    Abstract: The present invention provides isolated nucleic acids comprising nucleotide sequences encoding isoprenoid modifying enzymes, as well as recombinant vectors comprising the nucleic acids. The present invention further provides genetically modified host cells comprising a subject nucleic acid or recombinant vector. The present invention further provides a transgenic plant comprising a subject nucleic acid. The present invention further provides methods of producing an isoprenoid compound, the method generally involving culturing a subject genetically modified host cell under conditions that permit synthesis of an isoprenoid compound modifying enzyme encoded by a subject nucleic acid.
    Type: Grant
    Filed: June 29, 2006
    Date of Patent: April 24, 2012
    Assignee: The Regents of the University of California
    Inventors: Dae-Kyun Ro, Karyn Newman, Eric M. Paradise, Jay D. Keasling, Mario Ouellet, Rachel Eachus, Kimberly Ho, Timothy Ham
  • Patent number: 8163529
    Abstract: A nicking endonuclease is described which has an amino acid sequence with at least 70% identity to SEQ ID NO:6 and comprising a mutation at least one of an arginine or glutamic acid corresponding to position 507 and position 546 respectively in SEQ ID NO:6.
    Type: Grant
    Filed: October 18, 2010
    Date of Patent: April 24, 2012
    Assignee: New England Biolabs, Inc.
    Inventors: Shuang-Yong Xu, Zhenyu Zhu, Timothy Meixsell
  • Patent number: 8163528
    Abstract: The present invention provides isolated nucleic acid molecules encoding a Herpesviridae thymidine kinase enzyme comprising one or more mutations, at least one of the mutations encoding an amino acid substitution located toward the N-terminus from a DRH nucleoside binding site which increases a biological activity of the thymidine kinase, as compared to unmutated thymidine kinase. Such mutations include amino acid substitutions within a Q substrate binding domain which increases a biological activity of the thymidine kinase, as compared to unmutated thymidine kinase. Within a further aspect, fusion proteins are provided which have both guanylate kinase and thymidine kinase biological properties. Also provided are vectors suitable for expressing such DNA molecules, as well as methods for utilizing such vectors.
    Type: Grant
    Filed: December 29, 2010
    Date of Patent: April 24, 2012
    Assignee: Darwin Molecular Corporation
    Inventor: Margaret E Black
  • Patent number: 8163532
    Abstract: The present invention relates to microorganisms and methods for producing methionine by reactivation of the MetH enzyme.
    Type: Grant
    Filed: May 27, 2009
    Date of Patent: April 24, 2012
    Assignee: Evonik Degussa GmbH
    Inventors: Oskar Zelder, Hartwig Schröder, Corinna Klopprogge, Andrea Herold, Stefan Haefner, R. Rogers Yocum, Thomas A. Patterson, Mark Williams
  • Publication number: 20120096597
    Abstract: The present invention relates to isolated polypeptides having beta-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: January 28, 2010
    Publication date: April 19, 2012
    Applicants: Novozymes, Inc., Novozymes A/S
    Inventors: Kirk Schnorr, Michael Rey
  • Publication number: 20120094297
    Abstract: The present invention relates to a recombinant host cell, wherein the cell is modified to increase the expression levels of Ero1 and XBP1 relative to the expression levels of Ero1 and XBP1 in an unmodified cell. The present invention also relates to a method of producing a recombinant protein of interest comprising expressing the recombinant protein of interest in the recombinant host cell.
    Type: Application
    Filed: February 10, 2010
    Publication date: April 19, 2012
    Applicant: UCB PHARMA S.A.
    Inventors: Katharine Lacy Cain, Shirley Jane Peters, Paul Edward Stephens
  • Publication number: 20120096581
    Abstract: The present invention comprises crystalline polyketide synthases, isolated non-native polyketide synthases having the structural coordinates of said crystalline polyketide synthases, and nucleic acid encoding such non-native polyketide synthases. Also disclosed are methods of producing mutant polyketide synthases, and methods of altering the activity and/or substrate specificity of putative polyketide synthases.
    Type: Application
    Filed: October 4, 2010
    Publication date: April 19, 2012
    Inventors: Joseph P. Noel, Michael B. Austin, Marianne E. Bowman
  • Publication number: 20120094332
    Abstract: The present invention provides polypeptides having a nucleotide polymerase activity and method of enhancing polymerase activity. The polypeptides of the present invention may possess both a DNA-dependent DNA polymerase activity and an RNA-dependent DNA polymerase activity, i.e., a reverse transcriptase activity. The polypeptides of the present invention may be used in any application including, but not limited to, DNA sequencing reactions, amplification reactions, cDNA synthesis reactions, and combined cDNA synthesis and amplification reactions, e.g., RT-PCR.
    Type: Application
    Filed: December 30, 2010
    Publication date: April 19, 2012
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: Jun Lee, Gary Gerard, Harini Shandilya, Katherine R. Griffiths, Moreland D. Gibbs, Peter L. Bergquist, Robert Jason Potter
  • Publication number: 20120096593
    Abstract: The present invention relates generally to the field of molecular biology and concerns a method for improving various plant growth characteristics by modulating expression in a plant of a nucleic acid encoding a LDOX (leucoanthocyanidin dioxygenase) polypeptide, a nucleic acid encoding a YRP5, a nucleic acid encoding a CK1 (Casein Kinase type I) polypeptide, a nucleic acid encoding a bHLH12-like (basic Helix Loop Helix group polypeptide, a nucleic acid encoding an ADH2 polypeptide or a nucleic acid encoding a GCN5-like polypeptide. The present invention also concerns plants having modulated expression of a nucleic acid encoding an LDOX polypeptide, or a YRP5 polypeptide, or a CK1 polypeptide, or a bHLH12-like polypeptide, or an ADH2 polypeptide, or a GCN5-like polypeptide, which plants have improved growth characteristics relative to corresponding wild type plants or other control plants. The invention also provides constructs useful in the methods of the invention.
    Type: Application
    Filed: April 28, 2010
    Publication date: April 19, 2012
    Inventors: Yves Hatzfeld, Ana Isabel Sanz Molinero, Valerie Frankard, Christophe Reuzeau
  • Publication number: 20120096588
    Abstract: Transgenic soybean seed having increased total fatty acid content of at least 10% and altered fatty acid profiles when compared to the total fatty acid content of non-transgenic, null segregant soybean seed are described. DGAT genes from oleaginous organisms are used to achieve the increase in seed storage lipids.
    Type: Application
    Filed: December 16, 2011
    Publication date: April 19, 2012
    Applicant: E.I. du Pont de Nemours and Company
    Inventors: Knut Meyer, Howard Glenn Damude, Kevin G. Ripp, Kevin L. Stecca
  • Publication number: 20120093788
    Abstract: We have identified by molecular cloning a protease which originates from the larvae of Lucilia sericata and which was termed debrilase due to its activities useful for debridement of wounds.
    Type: Application
    Filed: March 3, 2010
    Publication date: April 19, 2012
    Applicant: B.R.A.I.N. Biotechnology Research and Information Network AG
    Inventors: Frank Niehaus, Jürgen Eck, Renate Schulze, Michael Krohn
  • Publication number: 20120094320
    Abstract: A protein comprising an amino acid sequence having at least one mutation selected from a Gly-4 to Ala mutation, a Glu-6 to His mutation, a Ser-14 to Thr mutation, an Ala-37 to Thr or Arg mutation, a Pro-50 to Gln mutation, a Glu-67 to Gly mutation, an Asp-80 to Tyr mutation, a Val-93 to Met mutation, an Arg-156 to Pro mutation, a Leu-164 to Met mutation, an Asn-202 to Asp mutation, a Thr-235 to Ala mutation, an Asn-348 to Tyr mutation, a Gly-362 to Arg mutation and a Val-473 to Ala mutation in the amino acid sequence depicted in SEQ II NO:4. (2) A thermostable protein which comprises an amino acid sequence derived from the amino acid sequence having at least one variation described in (1) and having 1,5-anhydroglucitol dehydrogenase activity. These proteins act specifically on 1,5-anhydroglucitol (1,5-AG), have thermal stability and exhibit excellent storage stability.
    Type: Application
    Filed: June 18, 2009
    Publication date: April 19, 2012
    Applicant: NIPPON KAYAKU KABUSHIKI KAISHA
    Inventors: Hideki Yoshioka, Shuhei Tsukamoto, Minoru Masuda, Reiko Machida, Yoshihiko Umegae, Masahiko Yabuuchi
  • Publication number: 20120094386
    Abstract: Provided herein are compositions and methods for engineering salt tolerance and producing products by photosynthetic organisms. The photosynthetic organisms can be genetically modified to be salt tolerant as compared to an unmodified organism and to produce useful products. The methods and compositions of the disclosure are useful in many therapeutic and industrial applications.
    Type: Application
    Filed: March 11, 2010
    Publication date: April 19, 2012
    Applicant: SAPPHIRE ENERGY, INC.
    Inventors: Michael Mendez, Su-Chiung Fang, Stephane Richard